scholarly journals Cancer and Pregnancy: A Comprehensive Review

Cancers ◽  
2021 ◽  
Vol 13 (12) ◽  
pp. 3048
Author(s):  
Roxana Schwab ◽  
Katharina Anic ◽  
Annette Hasenburg
Keyword(s):  
Premature Delivery ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Comprehensive Review ◽  
Risks And Benefits ◽  
Cancer In Pregnancy ◽  
Gestational Week ◽  
Tumor Entity ◽  
Challenging Situation

Cancer diagnosis and treatment in pregnant women is a challenging situation. A multidisciplinary network of specialists is required to guide both, the expecting mother and the unborn child through the diagnostic workup and the cytotoxic therapy, by balancing the respective risks and benefits. Tumor entity, stage, biology and gestational week at diagnosis determine the appropriate approach. As premature delivery emerged as one of the main risk factors for adverse long-term outcome of the progeny, it should be avoided, if reasonable from the oncological perspective. This article offers a comprehensive review with respect to the various aspects of cancer in pregnancy.

scholarly journals Best of ASCO 2021: new data from triple-negative breast cancer

2021 ◽  
Author(s):  
Christian Singer
Keyword(s):  
Breast Cancer ◽  
Triple Negative ◽  
Early Stage ◽  
Target Identification ◽  
Conventional Chemotherapy ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Tumor Entity ◽  
Cancer Setting

SummaryThis year’s ASCO Annual Meeting has been a showcase for the overwhelming success of novel, targeted therapies, particularly in a tumor entity that has – until recently – been felt to be only treatable with chemotherapy. New data are extremely encouraging, but also highlight the need for target identification beyond the classical clinicopathological factors. Both, the Olympia and the Neotala study have been performed in BRCA-mutated tumors, and their results clearly point to the necessity to offer germline testing to HER2-negative high risk early breast cancer. In addition, GeparNuevo once more highlights the fact that immunotherapy is here to stay, not only in the advanced breast cancer setting, but also in early stage breast cancer. The side effect profile is acceptable, and long-term outcome a real improvement to conventional chemotherapy.

Long-term outcome of treatment with cyclosporine IV for patients with intractable ulcerative colitis

2001 ◽  
Vol 120 (5) ◽  
pp. A624-A624 ◽  
Author(s):  
J ARTS ◽  
M ZEEGERS ◽  
G DHAENS ◽  
G VANASSCHE ◽  
M HIELE ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Term Outcome ◽  
Long Term Outcome

1519: Long Term Outcome of Interstitial Laser Coagulation for Benign Prostatic Hyperplasia

2006 ◽  
Vol 175 (4S) ◽  
pp. 490-490
Author(s):  
Stefan Zastrow ◽  
Sven Oehlschläger ◽  
Oliver W. Hakenberg ◽  
Steffen Leike ◽  
Manfred P. Wirth
Keyword(s):  
Benign Prostatic Hyperplasia ◽  
Prostatic Hyperplasia ◽  
Laser Coagulation ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Interstitial Laser

1306: Microvascular Arterial Bypass Surgery: Assessment of Long-Term Outcome

2006 ◽  
Vol 175 (4S) ◽  
pp. 420-421
Author(s):  
Gemma Viola Fantini ◽  
Andrew Nisbet ◽  
Pejman Mortarjem ◽  
Claudia Panzer ◽  
Ricardo Munarriz
Keyword(s):  
Bypass Surgery ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Arterial Bypass ◽  
Arterial Bypass Surgery

309: Surgery of Urachal Carcinoma – Evaluation of Long Term Outcome

2004 ◽  
Vol 171 (4S) ◽  
pp. 81-81
Author(s):  
Michael Cohen ◽  
Bernard H. Bochner ◽  
Harry W. Herr
Keyword(s):  
Term Outcome ◽  
Urachal Carcinoma ◽  
Long Term Outcome
Sign in / Sign up

Export Citation Format

Share Document